Benedikt Schoser

Nov 27, 2024 | onlinelibrary.wiley.com | Benedikt Schoser

Stroke and multisystemic features are easily overlooked in neuromuscular disorders (NMDs). The scientific literature is limited to this topic, and long-term outcomes are rarely reported. In this issue, Al-Salahat and colleagues report on cerebrovascular diseases (CVDs) outcomes in patients with muscular dystrophies (MD).

Aug 28, 2024 | onlinelibrary.wiley.com | Metabolic Diseases |Mike Horton |Stephan Wenninger |Benedikt Schoser

INTRODUCTION Pompe disease (glycogen storage disease type II or acid maltase deficiency, Online Mendelian Inheritance in Man ID: 232300) is a rare inherited metabolic disorder in which deficiency of acid α-glucosidase leads to lysosomal glycogen accumulation [1]. Late onset or nonclassic Pompe disease can present at any age and is characterized by slowly progressive skeletal and respiratory muscle weakness, often leading to wheelchair and/or ventilator dependency [2, 3].

Jun 9, 2023 | onlinelibrary.wiley.com | Riccardo Soffietti |David B. Vodušek |European Academy |Benedikt Schoser

European Training Requirements for Neurology (ETRN) In 2021 the President of the EAN (CB) and four members of the EAN board (CB, RS, DV, PB) started an in-depth revision of the ETRN 2016 version motivated by several considerations. First, knowledge in basic and clinical neurosciences is increasing exponentially. Secondly, the subspecialization in neurology is increasing. For example, in 2012 there were 25 neurological subspecialties recognized in the United States [22].